Dataset Information

Electron-Deficient Imidazolium Substituted Cp Ligands and their Ru Complexes.

ABSTRACT: The synthesis of electron-poor mono-, di- and tri(imidazolium)-substituted Cp-ylides is presented and their electronic properties are discussed based on NMR spectroscopy, X-ray structure analyses, electrochemical investigations and DFT calculations as well as by their reactivity toward [Ru(CH₃ CN)₃ Cp*](PF₆ ). With mono- and di(imidazolium)-substituted cyclopentadienides the respective monocationic and dicationic ruthenocences are formed (X-ray), whereas tri(imidazolium) cyclopentadienides are too electron-poor to form the ruthenocenes. Cyclic voltammetric analysis of the ruthenocenes shows reversible oxidation at a potential that increases with every additional electron-withdrawing imidazolium substituent at the Cp ligand by 0.53-0.55?V in an electrolyte based on a weakly coordinating anion. A reversible oxidation can be observed for the free 1,3-disubstituted ligand as well.

SUBMITTER: Mazzotta F

PROVIDER: S-EPMC7756557 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Electron-Deficient Imidazolium Substituted Cp Ligands and their Ru Complexes.

Mazzotta Fabio F Zitzer Georg G Speiser Bernd B Kunz Doris D

Chemistry (Weinheim an der Bergstrasse, Germany) 20200930 69

The synthesis of electron-poor mono-, di- and tri(imidazolium)-substituted Cp-ylides is presented and their electronic properties are discussed based on NMR spectroscopy, X-ray structure analyses, electrochemical investigations and DFT calculations as well as by their reactivity toward [Ru(CH3 CN)3 Cp*](PF6 ). With mono- and di(imidazolium)-substituted cyclopentadienides the respective monocationic and dicationic ruthenocences are formed (X-ray), whereas tri(imid ...[more]

PMID: 32996227

Similar Datasets

Project description:Cisplatin-based chemotherapy is a common regimen for bladder cancer, a life-threatening cancer with more than 500,000 new cases worldwide annually. Like many other metallodrugs, cisplatin causes severe side effects for its general toxicity. Organoruthenium is known for its structural stability, good anticancer activity, and possible low general toxicity. Here, we have prepared and characterized a series of water-soluble ruthenium-arene complexes with N,N'-chelating ligands: [Ru(II)-η6-arene-(4,4'-(X)2-2,2'-bipyridine)Cl]Cl (arene = p-cymene, X = C4H9 (1), COOH (2), COOCH3 (3), COOC2H5 (4); arene = benzene, X = C4H9 (5), COOCH3 (6), COOC2H5 (7)). These complexes are carefully characterized using single-crystal X-ray diffraction, UV-vis, IR, 1H NMR, and MALDI-TOF MS spectroscopy. Their DFT-calculated structural and thermodynamic properties are consistent with the experimental observations. Biophysicochemical studies of complex interaction with CTDNA and BSA supported by molecular docking simulations reveal suitable properties of 1-7 as anticancer agents. Cytotoxicities of 1-7 are evaluated on healthy human MCF-10a-breast epithelial and African green monkey Vero cells, and carcinoma human HepG-2-hepatic, T24-bladder, and EAhy-926-endothelial cells. All complexes exhibit much higher cytotoxicity for T24 than cisplatin. Particularly, 1 and 2 are also highly selective toward T24. Fluorescence imaging and flow cytometry demonstrate that 1 and 2 penetrate T24 cell membrane and induce early apoptosis at their respective IC50 concentrations, which ultimately lead to cell death. Statistical analysis suggests that the order of importance for T24 cell antiproliferation is protein binding, Log p, Ru-Cl bond length, while DNA binding is the least important. This study is the first to report the anti-bladder cancer efficacy of Ru-arene-2,2'-bipyridine complexes, and may provide insights for rational design of organoruthenium drugs in the enduring search for new chemotherapeutic agents.

Project description:The series of complexes [XRu(CO)(L-L)(L')2][PF6] (X = H, TFA, Cl; L-L = 2,2'-bipyridyl, 1,10-phenanthroline, 5-amino-1,10-phenanthroline and 4,4'-dicarboxylic-2,2'-bipyridyl; L'2 = 2PPh3, Ph2 PC2H4PPh2, Ph2PCH═CHPPh2) have been synthesized from the starting complex K[Ru(CO)3(TFA)3] (TFA = CF3CO2) by first reacting with the phosphine ligand, followed by reaction with the L-L and anion exchange with NaPF6. In the case of L-L = phenanthroline and L'2 = 2PPh3, the neutral complex Ru(Ph3P)(CO)(1,10-phenanthroline)( TFA)2 is also obtained and its solid state structure is reported. Solid state structures are also reported for the cationic complexes where L-L = phenanthroline, L2 = 2PPh3 and X = Cl and for L-L = 2,2'-bipyridyl, L2 = 2PPh3 and X = H. All the complexes were characterized in solution by a combination of 1H and 31P NMR, IR, mass spectrometry and elemental analyses. The purpose of the project was to synthesize a series of complexes that exhibit a range of excited-state lifetimes and that have large Stokes shifts, high quantum yields and high intrinsic polarizations associated with their metal-to-ligand charge-transfer (MLCT) emissions. To a large degree these goals have been realized in that excited-state lifetimes in the range of 100 ns to over 1 μs are observed. The lifetimes are sensitive to both solvent and the presence of oxygen. The measured quantum yields and intrinsic anisotropies are higher than for previously reported Ru(II) complexes. Interestingly, the neutral complex with one phosphine ligand shows no MLCT emission. Under the conditions of synthesis some of the initially formed complexes with X = TFA are converted to the corresponding hydrides or in the presence of chlorinated solvents to the corresponding chlorides, testifying to the lability of the TFA Ligand. The compounds show multiple reduction potentials which are chemically and electrochemically reversible in a few cases as examined by cyclic voltammetry. The relationships between the observed photophysical properties of the complexes and the nature of the ligands on the Ru(II) is discussed.

Dataset Information

Electron-Deficient Imidazolium Substituted Cp Ligands and their Ru Complexes.

Publications

Electron-Deficient Imidazolium Substituted Cp Ligands and their Ru Complexes.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets